FDA inspection

Fuji Yakuhin Co., Ltd.: FDA inspection ending Nov 25, 2022

FDA inspection 1192063 · Voluntary Action Indicated (VAI) · Toyama

Key facts

Inspection ID 1192063
Firm Fuji Yakuhin Co., Ltd.
FEI number 3008538640
Address 682, Fuchumachiitakura
City Toyama
Country Japan
Fiscal year 2023
Inspection end date Nov 25, 2022
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections